Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
aducanumab
advances in neurology
adverse drug reaction
agitation
Alzheimer's disease
Alzheimer's disease, age of onset
Alzheimer's disease, diagnosis of
Alzheimer's disease, early onset
Alzheimer's disease, early symptoms
Alzheimer's disease, familial
Alzheimer's disease, incidence
Alzheimer's disease, pathogenesis
Alzheimer's disease, preclinical
Alzheimer's disease, risk factors in
Alzheimer's disease, treatment of
Alzheimer's disease, vaccine
amnesia
amyloid
amyloid angiopathy, cerebral
amyloid angiopathy, cerebral, Boston criteria
amyloid angiopathy, cerebral, iatrogenic
amyloid angiopathy, cerebral, inflammatory type
amyloid beta protein
amyloid beta protein antibodies
amyloid beta-related angiitis
amyloid deposition
amyloid imaging
amyloid plaques
amyloidosis
amyloid-related imaging abnormalities
aneurysm, intracranial, familial
angiitis
angiitis, granulomatous of CNS
angiitis, isolated of CNS
angiography, cerebral
angiography, cerebral, false negative
angiography, cerebral, negative
anorectics
anti-amyloid therapy
anticholinesterase
anticoagulant, complications of
anticoagulant, contraindications
anticoagulant, discontinuation
anticoagulant, treatment
anticoagulant, treatment in CVD
anticonvulsants
aphasia
apolipoprotein E
APP
apraxia
apraxia, constructional
areflexia
asymptomatic
ataxia
ataxia, cerebellar
ataxia, hereditary
atrial fibrillation
behavioral disorder
biologic markers
blood pressure, control
blood transfusion
brain biopsy
CAT scan
CAT scan, abnormal
CAT scan, emission
CAT scan, emission, abnormal
CAT scan, false negative
central nervous system, infection of
cerebellar atrophy, primary
cerebellar atrophy, secondary
cerebellar degeneration
cerebellar plaques, amyloid
cerebral cortical atrophy
cerebral edema
cerebral edema, vasogenic
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, biochemical markers of CNS disease
cerebrospinal fluid, elevated protein of
cerebrospinal fluid, oligoclonal IgG in
cerebrospinal fluid, red cells in
cerebrospinal fluid, xanthochromia of
cerebrovascular accident
cerebrovascular accident, multiple
Clinical Pathologic Conference(C.P.C.)
cognition
coinfection
coma
complications
confusion
contraindications
controversies in neurology
cost
cost effectiveness
cryptococcal meningitis
cryptococcal meningoencephalitis
degenerative diseases of CNS
delusion
dementia
dementia, diagnostic evaluation of
dementia, early detection
dementia, familial
dementia, presenile
dementia, prevention of
dementia, rapidly progressive
dementia, reversible
dementia, screening for
dementia, transmissible
dementia, treatment of
depression
diagnostic criteria
differential diagnosis
disease modifying agents
disorientation
dizziness
donanemab
donepezil
dysarthria
dyskinesia
dyskinesia, buccal lingual facial
dyskinesia, drug induced
dysnomia
dyspraxia
echolalia
efficacy
electroencephalogram
electroencephalogram, abnormalities of
electromagnetic fields
encephalopathy
enzyme inhibition
epidemiology of neurology
executive dysfunction
facial weakness
false positive
familial
fatal familial insomnia
fenfluramine
fever
florbetapir
frontal lobe, anatomy and physiology
fungal infection
fungal infection, CNS
gadolinium
gait disorder
gene
gene mutation
genetic neurologic disorders
Gerstmann-Straussler-Scheinker disease
granulomatous disease
grasping
hallucination
hallucination, visual
head injury
headache
headache, severe
headache, sudden onset of
hematuria, microscopic
hemosiderosis of CNS, superficial
hemosiderosis, subarachnoid
hippocampal atrophy
hippocampus
histochemistry
histopathology
iatrogenic neurologic disorders
immunosuppression
immunosuppressive agents
immunotherapy
intellectual deterioration
intracerebral hemorrhage
intracerebral hemorrhage, lobar
intracerebral hemorrhage, location of
intracerebral hemorrhage, multiple
intracerebral hemorrhage, recurrent
intranasal medication
Jakob-Creutzfeldt disease
kuru
laughing, pathologic
lecanemab
leuko-araiosis
leukocytosis
level of consciousness, decreased
level of consciousness, fluctuating
memory, defect of recent
memory, evaluation of
memory, impairment of
memory, impairment of, subjective
memory, recent
meningeal biopsy
meningeal enhancement
meningoencephalitis
mental status, abnormal
microangiopathy, brain
microhemorrhage, intracerebral
microhemorrhage, intracerebral, location
mild cognitive impairment
mild cognitive impairment converting to Alzheimer's disease
mimics
Mini Mental Status Examination
misdiagnosis
mitochondrial disease
molecular genetics
mongolism
monoclonal antibodies
mortality
movement disorder
MRI
MRI, abnormal
MRI, contrast enhanced
MRI, disappearing lesion on
MRI, false negative
MRI, functional
MRI, gradient-echo
MRI, serial
MRI, sulcal hyperintensity
MRI, volumetry
multinucleated giant cell
myoclonic jerks
myoclonus
negative
neurofibrillary degeneration
neurologic complications of, surgery
neurologic disease
neurologic disease, diagnoses of
neurologic disease, multiple
neurologic examination, focal
neurologic testing
neuropathology
neuropathology, brain
neuroprotective agents
normal
old age, neurology of
opportunistic infection, CNS
paranoia
paraphasias
Parkinson disease
Parkinsonism syndrome
pathology
patient information and support
personality change
Pittsburgh Compound B
platelet inhibiting drugs
platelet inhibiting drugs, contraindications
pleocytosis of cerebrospinal fluid
preclinical
prevention of neurologic disorders
prion disease
prognosis
progressive neurologic disorder
psychological testing
psychosis
pursuit eye movements, abnormal
pyramidal tract dysfunction
rapidly progressing neurologic illness
recurrent
review article
risk factors
safety
screening
sedimentation rate, elevated
seizure
self-confidence
senile plaques
shared decision making
single photon emission computed tomography
small vessel disease
spongy degeneration of brain
startle myoclonus
statin therapy
statin therapy, discontinuation
steroid therapy, CNS treatment and complications with
subarachnoid hemorrhage
subarachnoid hemorrhage, cerebral convexity
tau protein
tauopathy
temporal lobe
tissue plasminogen activator, intravenous
TRAILBLAZER-ALZ trial
transient ischemic attack
transient neurologic deficit
treatment of neurologic disorder
vaccine
vasculitides
vasculopathy
Virchow-Robin spaces, dilated
virus, slow
visual loss
visuospatial disturbance
weight loss
white matter disease
white matter disease, subcortical
work performance
workup
Showing articles 650 to 700 of 1500 << Previous Next >>

Progressive Binasal Hemianopia
Lancet 363:1606, Pringle,E.,et al, 2004

Hemorrhage Burden Predicts Recurrent Intracerebral Hemorrhage After Lobar Hemorrhage
Stroke 35:1415-1420, Greenberg,S.M.,et al, 2004

Routine Use of Gradient-Echo MRI to Screen for Cerebral Amyloid Angiopathy in Elderly Patients
AJR 182:1547-1550, Walker,D.A., et al, 2004

Diffusion-Weighted MRI Abnormalities as an Early Diagnostic Marker for Creutzfeldt-Jakob Disease
Neurol 63:443-449,410, Shiga,Y.,et al, 2004

Sensitivity of 14-3-3 Protein Test Varies in Subtypes of Sporadic Creutzfeldt-Jakob Disease
Neurol 63:436-442,410, Castellani,R.J.,et al, 2004

Novel Methods for Disinfection of Prion-Contaminated Medical Devices
Lancet 364:521-526, Fichet,G.,et al, 2004

Preclinical vCJD After Blood Transfusion in a PRNP Codon 129 Heterozygous Patient
Lancet 364:527-529, Peden,A.H.,et al, 2004

Systemic Inflammatory Response Depends on Initial Stroke Severity but is Attenuated by Successful Thrombolysis
Stroke 35:2128, Audebert,H.J.,et al, 2004

Interferon Beta-1a for Brain Tissue Loss in Patients at Presentation with Syndromes Suggestive of Multiple Sclerosis: A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 364:1489-1496,1463, Filippi,M.,et al, 2004

White Matter Lesions, Congition, and Recurrent Hemorrhage in Lobar Intracerebral Hemorrhage
Neurol 63:1606-1612, Smith,E.E.,et al, 2004

The Metabolic Syndrome, Inflammation, and Risk of Cognitive Decline
JAMA 292:2237-2242, Yaffe,K.,et al, 2004

Interferon beta-1b in Secondary Progressive MS
Neurol 63:1779-1787,1768, Kappos,L.,et al, 2004

Interferon beta-1b in Secondary Progressive MS
Neurol 63:1788-1795,1768, The North American Study Group on Interferon beta-, 2004

CJD--A Case of Mistaken Identity
Lancet 364:2068, Campbell,S.,et al, 2004

Bickerstaff's Brainstem Encephalitis: Clinical Features of 62 Cases and a Subgroup Associated with Guillain-Barre Syndrome
Brain 126:2279-2290, Odaka,M.,et al, 2003

Rasmussen's Encephalitis
Neurol 60:422-425, Granata,T.,et al, 2003

Diffusion-Weighted Imaging Discriminates Progressive Supranuclear Palsy from PD, But Not From the Parkinson Variant of Multiple System Atrophy
Neurol 60:922-927, Seppi,K.,et al, 2003

POEMS Syndrome Associated with Ischemic Stroke
Arch Neurol 60:745-749, Kang, K.,et al, 2003

Antivonvulsants for Creutzfeldt-Jakob Disease?
Lancet 361:224, Fioel,A.,et al, 2003

Treatment of Sporadic Hemiplegic Migraine with Calcium-Channel Blocker Verapamil
Neurol 60:120-121, Yu,W. &Horowitz,S.H., 2003

An Organic Cause of Neuropsychiatric Illness in Adolescence
Lancet 361:572, Taylor,S.E.,et al, 2003

Interferons in Relapsing Remitting Multiple Sclerosis: A Systematic Review
Lancet 361:545-552, Filippini,G.,et al, 2003

Bilateral Striatal Necrosis Associated with Mycoplasma pneumoniae Infection
NEJM 348:720, van Vuiren,M. &Uhl,M., 2003

Detection of Pathologic Prion Protein in the Olfactory Epithelium in Sporadic Creutzfeldt-Jakob Disease
NEJM 348:711-719,681, Zanusso,G.,et al, 2003

Clinicopath Conf., Brain Abscess Due to Infection with Streptococcus milleri and Haemophilus aphrophilus
NEJM 348:2125-2132, Case 16:2003, 2003

Validation of Diagnositc Magnetic Resonance Imaging Criteria for Multiple Sclerosis and Response to Interferon B1a
Ann Neurol 53:718-724, Barkhof,F.,et al, 2003

Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis After a First Demyelinating Event
NEJM 349:139-145,107, Berger,T.,et al, 2003

Challenging the Clinical Utility of the 14-3-3 Protein for the Diagnosis of Sporadic Creutzfeldt-Jakob Disease
Arch Neurol 60:813-816,803, Geschwind,M.D.,et al, 2003

Clinicopath Conf., Giant-Cell Arteritis
NEJM 349:170-180, Case 21-2003, 2003

14-3-3 Protein in the CSF of Patients with Rapidly Progressive Dementia
Neurol 61:354-357, Huang,N.,et al, 2003

Clinical Importance of Neutralising Antibodies Against Interferon Beta in Patients with Relapsing-Remitting Multiple Sclerosis
Lancet 362:1184-1191, Sorensen,P.S.,et al, 2003

C-Reactive Protein Predicts Further Ischemic Events in First-Ever Transient Ischemic Attack or Stroke Patients With Intracrnial Large-Artery Occlusive Disease
Stroke 34:2463-2470, Arenillas,J.F.,et al, 2003

Autoantibodies to Glutamic Acid Decarboxylase in Downbeat Nystagmus
JNNP 74:998-999, Antonini,G.,et al, 2003

Subcortical Hematoma Caused by Cerebral Amyloid Angiopathy: Does the First Evidence of Hemorrhage Occur in the Subarachnoid Space?
Neuropathology 23:254-261, Takeda,S.,et al, 2003

Disease-Modifying Therapy in Multiple Sclerosis: Strategies for Optimizing Management
The Neurologist 8:227-236, Frohman,E.,et al, 2002

Paraneoplastic Chorea Associated with CRMP-5 Neuronal Antibody and Lung Carcinoma
Ann Neurol 51:625-630, Vernino,S.,et al, 2002

Interferon Beta-1a for Early Multiple Sclerosis: CHAMPS Trial Subgroup Analyses
Ann Neurol 51:481-490, Beck,R.W.,et al, 2002

Polymyalgia Rheumatica and Giant-Cell Arteritis
NEJM 347:261-271, Salvarani,C.,et al, 2002

Interferon Beta but not Glatiramer Acetate Therapy Aggravates Headaches in MS
Neurol 59:636-639, Pollmann,W.,et al, 2002

Benefit of Interferon B-1a on MSFC Progression in Secondary Progressive MS
Neurol 59:679-687, Cohen,J.A.,et al, 2002

Out of Africa, Trypanosomiasis
NEJM 347:749-753, Sahlas,D.J.,et al, 2002

Prospective Assessment of Risk Factors for Recurrent Stroke During Childhood--A 5-year Follow-up Study
Lancet 360:1540-1545,1526, Strater,R.,et al, 2002

A Randomized, Double-Blind, Dose-Comparison Study of Weekly Interferon B-1a in Relapsing MS
Neurol 59:1507-1517,1482, Clanet,M.,et al, 2002

Randomized, Comparative Study of Interferon B-1a Treatment Regimens in MS
Neurol 59:1496-1506,1482, Panitch,H.,et al, 2002

An Open-Label Trial of Combination Therapy With Interferon B-1a and Oral Methotrexate in MS
Neurol 58:314-317, Calabresi,P.A.,et al, 2002

Disease Modifying Therapies in Multiple Sclerosis
Neurol 58:169-178, Goodin,D.S.,et al, 2002

Tau Protein and 14-3-3 Protein in the Differential Diagnosis of Creutzfeldt-Jakob Disease
Neurol 58:192-197, Otto,M.,et al, 2002

Clinicopath Conf, Hyperviscosity Syndrome Due to IgG Multiple Myeloma
NEJM 346:603-610, Case 6-2002, 2002

The Neurological Masquerade of Intravascular Lymphomatosis
Arch Neurol 59:439-443, Beristain,X.&Azzarelli,B., 2002

Multifocal Myoclonus Due to Verapamil Overdose
Neurol 58:984-985, Vadlamudi,L.&Wijdicks,E.F.M., 2002



Showing articles 650 to 700 of 1500 << Previous Next >>